About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2020 Genitourinary Cancers Symposium
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
2020 Gastrointestinal Cancers Symposium
2019 San Antonio Breast Cancer Symposium
2019 ASH Annual Meeting & Exposition
Biomarkers in Immunotherapy
Methotrexate–Induced Kidney Injury
No results found for "Daniel F. Hayes, MD, FACP, FASCO"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
Talazoparib for Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer
HSD3B1 Genotype and Its Effect on Castration Resistance and Overall Survival in Prostate Cancer
IASLC Early Lung Imaging Confederation Initiative for Analysis of Low-Dose CT Images
Osimertinib Plus Savolitinib for EGFR-Mutated, MET-Amplified NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
PROs With Addition of Pembrolizumab vs Placebo to Pemetrexed and Platinum for Nonsquamous NSCLC
Most Read Stories
2020 GU Cancers Symposium: Talazoparib for Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer
Immune-Related Adverse Events in Patients With Cancer Receiving Influenza Vaccination During Treatment With Pembrolizumab
Progress in Treating Chronic Lymphocytic Leukemia Has Led to Across-the-board Improvements in Survival
Management of HER2-Positive Breast Cancer: Business as Usual?
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
© 2020 HSP News Service, L.L.C.